Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Cancer|April 1, 1993
Intensive recombinant interleukin-2 and alpha-interferon therapy in patients with advanced head and neck squamous carcinomaS G Urba, A A Forastiere, G T Wolf, et al.
International Journal of Immunopathology and Pharmacology|January 10, 2015
In silico modeling of the molecular interactions of antacid medication with the endothelium: novel therapeutic implications in head and neck carcinomasM Matossian, C Vangelderen, P Papagerakis, et al.
The Laryngoscope|June 1, 1992
Predictive value of objective esophageal insufflation testing for acquisition of tracheoesophageal speechE Callaway, J M Truelson, G T Wolf, et al.
The Laryngoscope|November 1, 1986
Small cell carcinoma of the larynx: results of therapyR F Baugh, G T Wolf, T F Beals, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 3, 1999
Health impact of head and neck cancerJ E Terrell, K Nanavati, R M Esclamado, et al.
The Laryngoscope|September 1, 1993
Ionized serum calcium levels following combined treatment for cancer of the head and neckY P Talmi, G T Wolf, R Esclamado, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 1, 1989
Interleukin 2 receptor expression in patients with head and neck squamous carcinoma. Effects of thymosin alpha 1 in vitroG T Wolf, J Hudson, K A Peterson, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 1993
Preservation of parotid function after external beam irradiation in head and neck cancer patients: a feasibility study using 3-dimensional treatment planningM B Hazuka, M K Martel, L Marsh, et al.
The Journal of Cell Biology|December 1, 1996
Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesionS Islam, T E Carey, G T Wolf, et al.
The Annals of Otology, Rhinology & Laryngology. Supplement|May 23, 1998
Functional outcomes following treatment for advanced laryngeal cancer. Part I--Voice preservation in advanced laryngeal cancer. Part II--Laryngectomy rehabilitation: the state of the art in the VA System. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study GroupR E Hillman, M J Walsh, G T Wolf, et al.
Pageof 11